| 1. | Kanaujiya, J. K., Lochab, S., Kapoor, I., Pal, P., Datta, D., Bhatt, M. L., Sanyal, S., Behre, G. and Trivedi, A. K. Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cells. Proteomics. 2013. 13, 2100-2112. [PubMed] |
2. | Singh, A. K., Arya, R. K., Trivedi, A. K., Sanyal, S., Baral, R., Dormond, O., Briscoe, D. M. and Datta, D. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. Cytokine & Growth Factor Reviews. 2013. 24, 41-49. [PubMed] | 3. | Banerjee, P., Basu, A., Datta, D., Gasser, M., Waaga-Gasser, A. M. and Pal, S. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. The Journal of Biological Chemistry. 2011. 286, 33580-33590. [PubMed] | 4. | Datta, D., Banerjee, P., Gasser, M., Waaga-Gasser, A. M. and Pal, S. CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. The Journal of Biological Chemistry. 2010. 285, 36842-36848. [PubMed] | 5. | Basu, A., Datta, D., Zurakowski, D. and Pal, S. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development. The Journal of Biological Chemistry. 2010. 285, 25196-25202. [PubMed] | 6. | Edelbauer, M., Datta, D., Vos, I. H., Basu, A., Stack, M. P., Reinders, M. E., Sho, M., Calzadilla, K., Ganz, P. and Briscoe, D. M. Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo. Blood. 2010. 116, 1980-1989. [PubMed] | 7. | Basu, A., Hoerning, A., Datta, D., Edelbauer, M., Stack, M. P., Calzadilla, K., Pal, S. and Briscoe, D. M. Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production. Journal of Immunology. 2010. 184, 545-549. [PubMed] | 8. | Datta, D., Contreras, A. G., Basu, A., Dormond, O., Flynn, E., Briscoe, D. M. and Pal, S. Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells. Cancer Research. 2009. 69, 8902-8909. [PubMed] | 9. | Dormond, O., Contreras, A. G., Meijer, E., Datta, D., Flynn, E., Pal, S. and Briscoe, D. M. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo. Journal of Immunology. 2008. 181, 8088-8095. [PubMed] | 10. | Datta, D., Contreras, A. G., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M. and Pal, S. Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression. Journal of the American Society of Nephrology : JASN. 2008. 19, 2437-2446. [PubMed] | 11. | Basu, A., Contreras, A. G., Datta, D., Flynn, E., Zeng, L., Cohen, H. T., Briscoe, D. M. and Pal, S. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Research. 2008. 68, 5689-5698. [PubMed] | 12. | Datta, D., Dormond, O., Basu, A., Briscoe, D. M. and Pal, S. Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells. American Journal of Physiology. Renal Physiology. 2007. 293, F1222-30. [PubMed] | 13. | Datta, D., Flaxenburg, J. A., Laxmanan, S., Geehan, C., Grimm, M., Waaga-Gasser, A. M., Briscoe, D. M. and Pal, S. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Research. 2006. 66, 9509-9518. [PubMed] |